Global Markets for Chiral Technology
May 08, 2012
Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR CHIRAL TECHNOLOGY (BIO012F) from BCC Research (www.bccresearch.com), the global market for chiral technology was valued at nearly $5.3 billion in 2011 and is expected to reach nearly $7.2 billion in 2016, a compound annual growth rate (CAGR) of 6.5%.
The chiral technology market can be broken down into three segments: chiral synthesis, chiral analysis, and chiral resolution.
The synthesis segment accounted for $4.2 billion in 2011 and is expected to reach $5.7 billion in 2016, a CAGR of 6.4%.
Analysis totaled $839.4 million in 2011 and should increase at a CAGR of 5.8% to reach $1.1 billion in 2016.
Chiral resolution, worth $207.5 million in 2011, should reach $322.5 million in 2016 at a CAGR of 9.2%.
This report provides a detailed market analysis of chiral-enabling products, including the factors influencing this market. New advancements and the need for enantiopure compounds have driven growth within this market. This study looks at most of the systems influenced by these factors.
There have been some significant developments in chiral technology-related areas during the past three years, such as various collaborative efforts between large drug providers and chiral-enabled product development companies to increase market share. In addition, the industry and research institutions have been using chiral techniques innovatively for the synthesis or separation of enantio-rich compounds.
This study contributes to the areas of market growth in therapeutic segments through chiral products and technologies from the point of view of manufacturers and users. The pharmaceutical and biopharmaceutical industries, agrochemical industries, physicians, hospitals, and research institutes will find this study to be of interest.
In addition to BIO012F, BCC also has published BIO101A, BIO102A, and BIO103A. These reports cover chiral technology with focuses, respectively, on the United States, Europe, and emerging markets.
Global Markets for Chiral Technology( BIO012F )
Publish Date: Apr 2012
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum